Research Alliance Corporation III filed Form S-4 on August 24, 2026.
The statement registers shares for the proposed acquisition of OHB Pediatrics Ltd. (Oak Hill Bio). RACC will domesticate to Delaware and rename to Oak Hill Bio Inc. prior to closing.
The Business Combination Agreement dated July 26, 2026 provides for RACC to acquire 100% of Oak Hill Bio shares in exchange for New OHB Common Stock.
$45 million in Oak Hill Bio SAFEs were issued concurrently by RA Capital affiliates at 8% interest. The SAFE Amount will be added to Base Equity Value.
PIPE subscription agreements were executed on the same date with qualified institutional buyers and accredited investors.
The filing includes the proxy statement for the extraordinary general meeting and the full Business Combination Agreement as Annex A.
Pulse Impact
- Previous Pulse: 71
- New Pulse: 82
- Change: +11
- Driver: The first registration statement opens the book and lifts Pulse off the listed baseline.
Research Alliance Corporation III Form S-4 (2026-08-24)
Not investment advice. Facts taken from the company’s Form S-4.